Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
BMC Pediatrics
Published in: BMC Pediatrics 1/2020

01-12-2020 | Phenylketonuria | Research article

Phenylketonuria screening in Iranian newborns: a systematic review and meta-analysis

Authors: Mehdi Shokri, Parviz Karimi, Hadis Zamanifar, Fatemeh Kazemi, Gholamreza Badfar, Milad Azami

Published in: BMC Pediatrics | Issue 1/2020

Login to get access

Abstract

Background

Phenylketonuria (PKU), which is characterized by a deficiency of phenylalanine hydroxylase activity, is an autosomal recessive disorder of phenylalanine (Phe) metabolism. Newborn screening is the main population-based public health screening program that allows successful identification and treatment of PKU with low-Phe diet. The aim of this study was to evaluate the epidemiology of PKU screening in Iranian newborns.

Methods

The present study was designed based on MOOSE protocol and reporting was done in accordance with the PRISMA guidelines. The protocol of this systematic review was published in PROSPERO before it was performed (CRD42020162626). A comprehensive search was done in 10/10/2019 to find related literature on international online databases Web of Science, Scopus, EMBASE, Science Direct, PubMed/Medline, EBSCO, CINAHL, Cochrane Library, national online databases and the Google Scholar search engine. Heterogeneity among studies was assessed by I2 index and Q test. All meta-analyses were performed using Comprehensive Meta-Analysis Software ver. 2. P < 0.05 was considered significant.

Result

Finally, 18 studies with 3,339,327 Iranian neonates were included. The prevalence of suspected hyperphenylalaninemia (HPA) was estimated to be 45.6/100,000 (95% CI: 23.9–87.1). The prevalence of suspected HPA in girls and boys infants in Iran was estimated to be 38.0/100,000 (95% CI: 15.1-95.5) and 43.3/100,000 (95% CI: 16.2-116.2), respectively. The prevalence of PKU was estimated to be 16.5/100,000 (95% CI: 12.9–21.2). The prevalence of PKU in girls and boys infants was estimated to be 13.3/100,000 (95% CI: 7.5–15.8) and 10.9/100,000 (95% CI: 7.5–15.8), respectively. The prevalence of mild to moderate HPA was estimated 9.7/100,000 (95% CI: 5.1–18.4) and the prevalence of classical PKU was estimated 4.4/100,000 (95% CI: 2.5–7.8). Sensitivity analysis for all meta-analysis with the omission of one study showed that overall estimation is still robust.

Conclusion

The results of this meta-analysis showed that PKU is prevalent in Iranian neonates. It should be considered that for PKU there is a highly effective dietary treatment which can prevent the clinical symptoms of PKU if initiated early after detection by newborn screening.
Appendix
Available only for authorised users
Literature
1.
Mitchell JJ, Trakadis YJ, Scriver CR. Phenylalanine hydroxylase deficiency. Genet Med. 2011;13(8):697-707.
2.
van Spronsen FJ, van Wegberg AM, Ahring K, Bélanger-Quintana A, Blau N, Bosch AM, et al. Key European guidelines for the diagnosis and management of patients with phenylketonuria. Lancet Diabetes Endocrinol. 2017;5(9):743–56.PubMedCrossRef
3.
Van Wegberg A, MacDonald A, Ahring K, Bélanger-Quintana A, Blau N, Bosch A, et al. The complete European guidelines on phenylketonuria: diagnosis and treatment. Orphanet J Rare Dis. 2017;12(1):162.PubMedPubMedCentralCrossRef
4.
Mitchell JJ, Trakadis YJ, Scriver CR. Phenylalanine hydroxylase deficiency. Genet Med. 2011;13(8):697.PubMedCrossRef
5.
Blau N, Bélanger-Quintana A, Demirkol M, Feillet F, Giovannini M, MacDonald A, et al. Management of phenylketonuria in Europe: survey results from 19 countries. Mol Genet Metab. 2010;99(2):109–15.PubMedCrossRef
6.
Guthrie R, Susi A. A simple phenylalanine method for detecting phenylketonuria in large populations of newborn infants. Pediatrics. 1963;32(3):338–43.PubMedCrossRef
7.
McCabe LL, Therrell BL Jr, McCabe ER. Newborn screening: rationale for a comprehensive, fully integrated public health system. Mol Genet Metab. 2002;77(4):267–73.PubMedCrossRef
8.
Alfadhel M, Al Othaim A, Al Saif S, Al Mutairi F, Alsayed M, Rahbeeni Z, et al. Expanded newborn screening program in Saudi Arabia: incidence of screened disorders. J Paediatr Child Health. 2017;53(6):585–91.PubMedCrossRef
9.
Yamaguchi A, Mizushima Y, Fukushi M, Shimizu Y, Kikuchi Y, Takasugi N. Microassay system for newborn screening for phenylketonuria, maple syrup urine disease, homocystinuria, histidinemia and galactosemia with use of a fluorometric microplate reader. Screening. 1992;1(1):49–62.CrossRef
10.
Contreras J, Alonso E, Fuentes LE. HPLC for confirmatory diagnosis and biochemical monitoring of Cuban patients with hyperphenylalaninemias. Medicc Rev. 2015;17:23–8.PubMedCrossRef
11.
Elvers L, Diependaal G, Blonk H, Loeber J. Phenylketonuria screening using the Quantase phenylalanine kit in combination with a microfilter system and the dye Tartrazine. Screening. 1995;3(4):209–23.CrossRef
12.
Schulze A, Kohlmueller D, Mayatepek E. Sensitivity of electrospray-tandem mass spectrometry using the phenylalanine/tyrosine-ratio for differential diagnosis of hyperphenylalaninemia in neonates. Clin Chim Acta. 1999;283(1–2):15–20.PubMedCrossRef
13.
Thiboonboon K, Leelahavarong P, Wattanasirichaigoon D, Vatanavicharn N, Wasant P, Shotelersuk V, et al. An economic evaluation of neonatal screening for inborn errors of metabolism using tandem mass spectrometry in Thailand. PLoS One. 2015;10(8):e0134782.PubMedPubMedCentralCrossRef
14.
Senemar S, Ganjekarimi H, Fathzadeh M, Tarami B, Bazrgar M. Epidemiological and clinical study of phenylketonuria (PKU) disease in the National Screening Program of neonates, Fars province, southern Iran. Iran J Public Health. 2009;38(2):58–64.
15.
Habib A, Fallahzadeh MH, Kazeroni HR, Ganjkarimi AH. Incidence of phenylketonuria in southern Iran. Iran J Med Sci. 2010;35(2):137–9.
16.
Abbaskhanian A, Zamanfar D, Afshar P, Asadpoor E, Rouhanizadeh H, Jafarnia A, et al. Incidence of neonatal Hyperphenylalaninemia based on high-performance liquid chromatography confirmatory technique in Mazandaran Province, northern Iran (2007–2015). Int J Prev Med. 2017;8:93.PubMedPubMedCentral
17.
Ordooei M, Jafarizadeh M, Mirzaei M, Ashoori H, Zare A, Shojaeifar H. Prevalence of neonatal hyperphenylalaninemia in Yazd Province, Iran. Iran J Med Sci. 2015;40(3):292–3.PubMedPubMedCentral
18.
Motamedi N, Goodarzi E, Pordanjani SR, Valizadeh R, Moradi Y, Sohrabivafa M, et al. Incidence of phenylketonuria in Lorestan province, west of Iran (2006-2016). Int J Pediatrics-Mashhad. 2017;5:4713–21.
19.
Ajami AMF, Lamuchi P, Koohi A. Assessment of the prevalence of of phenylketonuria and its different forms in Isfahan province. J Lab Diagn. 2013;5(22):P896.
20.
Nasiri S, KHOSRAVI H. Phenylketonuria disease prevalence in children of South Khorasan Province from September 2013 to November 2014. J Lab Diagn. 2013;5(22):P123.
21.
Sadrani NM, Zaifizadeh M, Hazrati S, Mohammadzadeh MSS. Prevalence of Phenylketonuria in Newborns in Ardebil by Screening and Analyzing the Results. Tehran: The 8th International & 13th National Congress on Quality Improvement in Clinical Laboratories; 2013.
22.
Morovatdar N, Aval SB, Yazdi SMRH, Norouzi F, Mina T. The epidemiological and clinical study of phenylketonuria (PKU) patients in Khorasan, North-eastern Iran. Iran J Neonatol. 2015;6(1):19.
23.
Saadatinasab Z, Sharifzadeh G. Incidence of phenylketonuria in southern Khorasan (2012-2014). J Birjand Univ Med Sci. 2015;22(3):286–92.
24.
Badiee M, Kameli M, Sharifi S, Hosaini F. Prevalence of congenital phenylketonuria in neonates born in Torbate Heydarieh during 2011-2013. J Univ Med Sci Torbate Heydarieh. 2014;2(1):28–34.
25.
Karamifar H, Ordoei M, Karamizadeh Z, Amirhakimi GH. Incidence of neonatal hyperphenylalaninemia in Fars province, South Iran. Iran J Pediatr. 2010;20(2):216.PubMedPubMedCentral
26.
Soori MBN, Sharifi A, Selgi M. Prevalence of neonatal phenylketonuria in Nahavand city in 2015–2016 and evaluation of the importance of phenylketonuria screening in neonates. Sari: The 3rd National Conference on Biology at Payam Noor University; 2018.
27.
Heydari A, Samavat A, Haj Valizadeh F, Mansoura L. The incidence of phenylketonuria in Iran in 2013. Tehran: The 9th University Student Conference on Innovations in Health Sciences; 2016.
28.
Ganji F, Naseri H, Rostampour N, Sedighi M, Lotfizadeh M. Assessing the phenylketonuria screening program in newborns, Iran 2015-2016. Acta Med Iran. 2018;56(1):49–55.
29.
Mahmoodi M, Nasrabadi AG, Rajabloo A, Khatti T. Assessment of the Prevalence of Phenylketonuria and its Diffrent Forms in Golestan Province. Tehran: The 8th International & 13th National Congress on Quality Improvement in Clinical Laboratories; 2015.
30.
Behineh M, Jafari M, Pirouzi A, Rasti G, Pashangpour Z. The Prevalence of Phenylketonuria (PKU) in Infants Referred to the Health Center of Khonj. Tehran: The 8th International & 13th National Congress on Quality Improvement in Clinical Laboratories; 2013.
31.
Rezabigidavarani EKN, Arefi S, Faryabi R. Investigation of phenylketonuria incidence in Kerman city during 2012–2013. Tehran: The 11th University Student Conference on Innovation in Health Sciences; 2018.
32.
Tavan H, Mohammadi I, Carson KV, Sayehmiri K, Sayehmiri F. Prevalence of Epilepsy in Iran: A Meta-Analysis and Systematic Review. Iran J Child Neurol. 2014;8(4):9–17.PubMedPubMedCentral
33.
Karimian M, Salamati M, Milad Azami M. The relationship between metabolic syndrome and increased risk of Barrett’s esophagus: an updated systematic review and meta-analysis. BMC Gastroenterology. 2020;20(138).
34.
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. Bmj. 2015;349:g7647.CrossRef
35.
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Jama. 2000;283(15):2008–12.PubMedCrossRef
36.
Leonardo R. PICO: model for clinical questions. Evid Based Med Pract. 2018;3(115):2.
37.
Peterson J, Welch V, Losos M, Tugwell P. The Newcastle-Ottawa scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa: Ottawa Hospital Research Institute; 2011.
38.
Higgins P, Green S. Cochrane Handbook for Systematic Reviews of Interventions (Version 5.1. 0) Available from: http://​handbook.​ cochrane. org/front_page. htm. Accessed on December 4th. 2015;2011.
39.
Ades A, Lu G, Higgins J. The interpretation of random-effects meta-analysis in decision models. Med Decis Mak. 2005;25(6):646–54.CrossRef
40.
Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–101.PubMedCrossRef
41.
42.
Sutivijit Y, Banpavichit A, Wiwanitkit V. Prevalence of neonatal hypothyroidism and phenylketonuria in southern Thailand: a 10-year report. Indian J Endocrinol Metab. 2011;15(2):115.PubMedPubMedCentralCrossRef
43.
Pourfarzam M, Zadhoush F. Newborn screening for inherited metabolic disorders; news and views. J Res Med Sci. 2013;18(9):801.PubMedCentral
44.
Farhud DD, Kabiri M. Incidence of phenylketonuria (PKU) in Iran. Indian J Pediatr. 1982;49(400):685–8.PubMedCrossRef
45.
Golipoor Z, Kashani IR, Akbari M, Mahmoudi R, Abbasi M, Nekoonam S. Incidence of Phenylketonuria in Southern Iran. Iran J Med Sci. 2010;35(2):37–9.
46.
Geelhoed E, Lewis B, Hounsome D, O'Leary P. Economic evaluation of neonatal screening for phenylketonuria and congenital hypothyroidism. J Paediatr Child Health. 2005;41(11):575–9.PubMedCrossRef
47.
Lord J, Thomason MJ, Littlejohns P, Chalmers RA, Bain MD, Addison GM, et al. Secondary analysis of economic data: a review of cost-benefit studies of neonatal screening for phenylketonuria. J Epidemiol Community Health. 1999;53(3):179–86.PubMedPubMedCentralCrossRef
48.
Thomason MJ, Lord J, Bain MD, Chalmers RA, Littlejohns P, Addison GM, et al. A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism. J Public Health. 1998;20(3):331–43.CrossRef
49.
Dhondt JL. Strategy for the screening of tetrahydrobiopterin deficiency among hyperphenylalaninaemic patients: 15-years experience. J Inherit Metab Dis. 1991;14(2):117–27.PubMedCrossRef
50.
Opladen T, Hoffmann GF, Blau N. An international survey of patients with tetrahydrobiopterin deficiencies presenting with hyperphenylalaninaemia. J Inherit Metab Dis. 2012;35(6):963–73.PubMedCrossRef
51.
Hardelid P, Cortina-Borja M, Munro A, Jones H, Cleary M, Champion M, et al. The birth prevalence of PKU in populations of European, south Asian and sub-Saharan African ancestry living in south East England. Ann Hum Genet. 2008;72(1):65–71.PubMed
52.
Ohlsson A. Neonatal screening in Sweden and disease-causing variants in phenylketonuria, galactosaemia and biotinidase deficiency; 2016.
Metadata
Title
Phenylketonuria screening in Iranian newborns: a systematic review and meta-analysis
Authors
Mehdi Shokri
Parviz Karimi
Hadis Zamanifar
Fatemeh Kazemi
Gholamreza Badfar
Milad Azami
Publication date
01-12-2020
Publisher
BioMed Central
Published in
BMC Pediatrics / Issue 1/2020
Electronic ISSN: 1471-2431
DOI
https://doi.org/10.1186/s12887-020-02230-6

Other articles of this Issue 1/2020

BMC Pediatrics 1/2020 Go to the issue

Research article

Associations of participation in organized sports and physical activity in preschool children: a cross-sectional study

Case report

Tonsillar hypertrophy and prolapse in a child – is epiglottitis a predisposing factor for sudden unexpected death?

Research article

Dynamics of toxigenic Clostridium perfringens colonisation in a cohort of prematurely born neonatal infants

Research article

Change in popliteal angle and hamstrings spasticity during childhood in ambulant children with spastic bilateral cerebral palsy. A register-based cohort study

Research article

Multicenter investigation of pediatric gastrointestinal tract magnets ingestion in China

Research article

The detrimental impacts of smart technology device overuse among school students in Kuwait: a cross-sectional survey